ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Genpharmasec Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor reported full compliance with SEBI regulations, noting no material deviations or penalties.
Genpharmasec Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, Satellite Corporate Services, confirmed that no physical share certificates were received for dematerialization during the quarter. This is a routine compliance disclosure.